Loading...

Home
Stock
MDGL

MDGL News & Events

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Forecast Technical Valuation Financials Earnings Should I Buy News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

MDGL News

Sagimet Stock Increases Following Acne Treatment Success

5 days agoBarron's

AIG Stock Drops 10.05% Following Leadership Transition Announcement

Jan 11 2026Benzinga

U.S. Markets Finished Higher on Friday; Sandisk Saw Notable Gains

Jan 09 2026Barron's

Madrigal Secures Exclusive License from Pfizer for Ervogastat with $50M Upfront Payment

Jan 09 2026Newsfilter

Madrigal Pharmaceuticals Downgraded to Hold, Shares Drop Over 5%

Jan 07 2026NASDAQ.COM

Madrigal Pharmaceuticals Downgraded by Wolfe Research, Stock Drops Over 5%

Jan 07 2026Fool

Nektar Therapeutics Faces Risks as Madrigal Pharmaceuticals Reports $287.3M in Sales

Jan 05 2026Fool

Nektar's Drug Uncertainty vs. Madrigal's Strong Sales Performance

Jan 05 2026NASDAQ.COM

MDGL Events

No data

No data

MDGL Monitor News

Madrigal Pharmaceuticals hits 20-day low amid market decline

Madrigal Pharmaceuticals stock declines amid market gains

Madrigal Secures Exclusive License from Pfizer for Ervogastat

Madrigal Pharmaceuticals downgraded, stock drops over 5%

Madrigal Pharmaceuticals stock rises amid market context

Madrigal Pharmaceuticals sees stock drop amid market strength

Madrigal Pharmaceuticals rises amid sector rotation despite market decline

MDGL.O Surges Past 5-Day SMA Amid Positive Sentiment

MDGL Earnings Analysis

Madrigal Pharmaceuticals Q3 2025 Earnings Surge- Intellectia AI™

Madrigal Pharma Q2 2025: Strong Growth & Future Prospects- Intellectia AI™

Madrigal Pharmaceuticals Earnings: Rezdiffra Launch Success- Intellectia AI™

People Also Watch